When we look at how much money they make before expenses, they keep 0.848% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.718%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.553%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.612% return, is a testament to Pieris Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. Pieris Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.836%. Furthermore, the proficiency of Pieris Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable -1.149% return on capital employed.
Stock Prices
Pieris Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $11.94, while its low point bottomed out at $11.5. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Pieris Pharmaceuticals, Inc.'s stock market.
Liquidity Ratios
Analyzing PIRS liquidity ratios reveals its financial health of the firm.
The current ratio of 324.44% gauges short-term asset coverage for liabilities.
The quick ratio (271.81%) assesses immediate liquidity, while the cash ratio (145.92%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
324.44%
Quick Ratio
271.81%
Cash Ratio
145.92%
Profitability Ratios
PIRS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -57.33% underscores its earnings before tax deductions.
The effective tax rate stands at -50.05%, revealing its tax efficiency.
The net income per EBT, 96.45%, and the EBT per EBIT, 79.85%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of -71.80%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-57.33%
Effective Tax Rate
-50.05%
Net Income per EBT
96.45%
EBT per EBIT
79.85%
EBIT per Revenue
-71.80%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 3.24, it details the span from stock purchase to revenue.
The 3 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 708.89% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
272
Operating Cycle
51.49
Days of Payables Outstanding
190
Cash Conversion Cycle
-138
Receivables Turnover
7.09
Payables Turnover
1.92
Asset Turnover
1.11
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -43.52, and free cash flow per share, -43.66, depict cash generation on a per-share basis.
The cash per share value, 21.32, showcases liquidity position.
Lastly, the operating cash flow sales ratio, -1.26, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
-43.52
Free Cash Flow per Share
-43.66
Cash per Share
21.32
Operating Cash Flow Sales Ratio
-1.26
Free Cash Flow to Operating Cash Flow Ratio
1.00
Capital Expenditure Coverage Ratio
-314.73
Dividend Paid and Capex Coverage Ratio
-314.73
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 38.03, provides a glimpse into top-line earnings distributed across each share.
Net income per share, -21.80, reflects the portion of profit attributed to each share.
The book value per share, 23.77, represents the net asset value distributed per share, while the tangible book value per share, 23.77, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
38.03
Net Income Per Share
-21.80
Book Value Per Share
23.77
Tangible Book Value Per Share
23.77
Shareholders Equity Per Share
23.77
Capex Per Share
-0.15
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 65.28%, indicates top-line expansion, while the gross profit growth, 77.45%, reveals profitability trends.
EBIT growth, 63.56%, and operating income growth, 63.56%, offer insights into operational profitability progression.
The net income growth, 21.47%, showcases bottom-line expansion, and the EPS growth, -5090.48%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
65.28%
Gross Profit Growth
77.45%
EBIT Growth
63.56%
Operating Income Growth
63.56%
Net Income Growth
21.47%
EPS Growth
-5090.48%
EPS Diluted Growth
-5090.48%
Weighted Average Shares Growth
-98.48%
Weighted Average Shares Diluted Growth
-98.48%
Operating Cash Flow Growth
10.20%
Free Cash Flow Growth
11.45%
10-Year Revenue Growth per Share
5235.84%
5-Year Revenue Growth per Share
6836.10%
3-Year Revenue Growth per Share
6965.14%
10-Year Operating CF Growth per Share
-21442.29%
5-Year Operating CF Growth per Share
-237943.47%
3-Year Operating CF Growth per Share
-5574.72%
10-Year Net Income Growth per Share
-456669.19%
5-Year Net Income Growth per Share
-4225.31%
3-Year Net Income Growth per Share
-3090.20%
10-Year Shareholders Equity Growth per Share
56225.27%
5-Year Shareholders Equity Growth per Share
3059.21%
3-Year Shareholders Equity Growth per Share
4073.47%
Receivables Growth
3.94%
Asset Growth
-59.49%
Book Value per Share Growth
6212.15%
Debt Growth
-100.00%
R&D Expense Growth
-24.46%
SGA Expenses Growth
2.80%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -1,004,352, captures the company's total value, considering both debt and equity.
Income quality, 2.19, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.39, gauges operational efficiency, while the research and development to revenue, 93.48%, highlights investment in innovation.
cards.indicator
cards.value
Enterprise Value
-1,004,352
Income Quality
2.19
Sales General and Administrative to Revenue
0.39
Research and Development to Revenue
93.48%
Capex to Operating Cash Flow
0.32%
Capex to Revenue
-0.40%
Capex to Depreciation
-9.60%
Stock-Based Compensation to Revenue
7.82%
Graham Number
107.97
Return on Tangible Assets
-63.45%
Graham Net Net
16.85
Working Capital
26,758,000
Tangible Asset Value
26,758,000
Net Current Asset Value
26,758,000
Average Receivables
5,924,500
Average Payables
3,763,000
Days Sales Outstanding
51
Days Payables Outstanding
691
ROIC
-59.21%
ROE
-0.92%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.52, and the price to book ratio, 0.52, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 0.32, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, -0.26, and price to operating cash flows, -0.26, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
0.52
Price to Book Ratio
0.52
Price to Sales Ratio
0.32
Price Cash Flow Ratio
-0.26
Enterprise Value Multiple
8.06
Price Fair Value
0.52
Price to Operating Cash Flow Ratio
-0.26
Price to Free Cash Flows Ratio
-0.26
Price to Tangible Book Ratio
0.61
Enterprise Value to Sales
-0.02
Enterprise Value Over EBITDA
0.07
EV to Operating Cash Flow
0.02
Earnings Yield
-149.73%
Free Cash Flow Yield
-329.38%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
